Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,494 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,594 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01465815 | Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) | withdrawn | Phase 1 / Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01799161 | Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer | withdrawn | Phase 1 | 0 | Eckhard PodackOTHER | 0 | Nov 17, 2014 |
| clinicaltrials |
| NCT00378235 | Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma | withdrawn | Phase 1 / Phase 2 | 0 | INSYS Therapeutics IncINDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01611584 | A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer | withdrawn | Phase 1 | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT02238522 | Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML | withdrawn | Phase 1 | 0 | Zenith EpigeneticsINDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT00787488 | Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca | withdrawn | N/A | 0 | Mark DewhirstOTHER | 0 | Nov 11, 2014 | clinicaltrials |
| NCT00108186 | Celecoxib Treatment for Lung Cancer | withdrawn | Phase 1 | 0 | US Department of Veterans AffairsFED | 1 | Oct 29, 2014 | clinicaltrials |
| NCT01320787 | 18-F-Fluoroacetate as PET Imaging Agent | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 23, 2014 | clinicaltrials |
| NCT00808145 | Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) | withdrawn | Phase 2 | 0 | Lahey ClinicOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT01791998 | Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer | withdrawn | N/A | 0 | University of ChicagoOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT01939483 | A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases | withdrawn | N/A | 0 | University of California, IrvineOTHER | 0 | Oct 8, 2014 | clinicaltrials |
| NCT02115594 | Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer(ENCORE305) | withdrawn | Phase 2 | 0 | Syndax PharmaceuticalsINDUSTRY | 1 | Oct 8, 2014 | clinicaltrials |
| NCT01952886 | Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients | withdrawn | Phase 2 | 0 | Duke UniversityOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00731705 | In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells | withdrawn | — | 0 | Indiana UniversityOTHER | 0 | Sep 19, 2014 | clinicaltrials |
| NCT01057355 | Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms | withdrawn | Phase 1 | 0 | Mayo ClinicOTHER | 0 | Sep 19, 2014 | clinicaltrials |
| NCT00967512 | Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course | withdrawn | Phase 2 | 0 | Eleos, Inc.INDUSTRY | 0 | Sep 18, 2014 | clinicaltrials |
| NCT02017678 | Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin | withdrawn | Phase 2 | 0 | Andrea McCartOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT01943058 | Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 0 | Sep 10, 2014 | clinicaltrials |
| NCT01859182 | Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Sep 9, 2014 | clinicaltrials |
| NCT01718223 | Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Sep 3, 2014 | clinicaltrials |
| NCT01284205 | First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC | withdrawn | Phase 3 | 0 | Bioniche Life Sciences Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT02115035 | A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib | withdrawn | Phase 1 / Phase 2 | 0 | University of ArkansasOTHER | 1 | Aug 27, 2014 | clinicaltrials |
| NCT02013726 | MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue | withdrawn | N/A | 0 | Gamma Medica, Inc.INDUSTRY | 0 | Aug 25, 2014 | clinicaltrials |
| NCT01688752 | Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia | withdrawn | — | 0 | University of MinnesotaOTHER | 0 | Aug 22, 2014 | clinicaltrials |
| NCT01175499 | Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract(TNFE-NBI) | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | Aug 19, 2014 | clinicaltrials |
| NCT02095574 | A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma | withdrawn | Phase 1 | 0 | AbbVieINDUSTRY | 0 | Aug 13, 2014 | clinicaltrials |
| NCT01606358 | Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer(IClyCO) | withdrawn | — | 0 | Rennes University HospitalOTHER | 1 | Aug 11, 2014 | clinicaltrials |
| NCT00458744 | Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment | withdrawn | Phase 1 | 0 | Children's Oncology GroupNETWORK | 0 | Aug 8, 2014 | clinicaltrials |
| NCT01574677 | Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test | withdrawn | — | 0 | Epigenomics, IncINDUSTRY | 1 | Aug 4, 2014 | clinicaltrials |
| NCT02205463 | KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer | withdrawn | Phase 1 | 0 | NYU Langone HealthOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01550380 | BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers(BKM120) | withdrawn | Phase 2 | 0 | University of UtahOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01688414 | Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Jul 29, 2014 | clinicaltrials |
| NCT01627080 | Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 28, 2014 | clinicaltrials |
| NCT01938456 | Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer | withdrawn | Phase 1 | 0 | GlaxoSmithKlineINDUSTRY | 0 | Jul 28, 2014 | clinicaltrials |
| NCT00907699 | Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507 | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jul 24, 2014 | clinicaltrials |
| NCT01913067 | Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC(CRANIAL) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 1 | Jul 24, 2014 | clinicaltrials |
| NCT02054793 | Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) | withdrawn | Phase 1 / Phase 2 | 0 | Emmanuel Antonarakis, MDOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT01722175 | Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer(ALPPS) | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Jul 22, 2014 | clinicaltrials |
| NCT01864070 | Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 22, 2014 | clinicaltrials |
| NCT00610662 | Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear | withdrawn | — | 0 | British Columbia Cancer AgencyOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT01941173 | Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT01669668 | Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma) | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Jul 16, 2014 | clinicaltrials |
| NCT02114502 | Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 11, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT01432314 | Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)(RTANDTACE) | withdrawn | Phase 2 | 0 | Asan Medical CenterOTHER | 0 | Jun 26, 2014 | clinicaltrials |
| NCT00974129 | A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas | withdrawn | — | 0 | Yale UniversityOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00616590 | Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer | withdrawn | — | 0 | Vanderbilt UniversityOTHER | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00907504 | Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer(ADVIGO1017) | withdrawn | Phase 3 | 0 | PfizerINDUSTRY | 0 | Jun 17, 2014 | clinicaltrials |
| NCT01228942 | A Prospective Trial of COXEN Chemotherapy Prediction | withdrawn | N/A | 0 | University of VirginiaOTHER | 0 | Jun 6, 2014 | clinicaltrials |
| NCT02055196 | Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | Jun 2, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 19, 2014source: clinicaltrials